Immunitybio Inc (IBRX)

Immunitybio Inc Azioni (IBRX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	15.91%51.24	44.21	38.29	32.06	26.43
Cost Of Revenue	25.21%0.30	0.24	0.38	0.18	0.14
Costs And Expenses	0.93%112.94	114.00	102.97	87.69	97.71
Operating Income/Loss	11.60%-61.70	-69.79	-64.68	-55.63	-71.29
Nonoperating Income/Loss	70.04%-168.69	-563.00	2.59	-11.68	-21.02
Income/Loss From Continuing Operations Before Tax	63.59%-230.39	-632.79	-62.09	-67.31	-92.31
Income Tax Expense/Benefit	100.00%-	0.01	-0.14	-0.04	0.27
	63.59%-230.39	-632.80	-61.96	-67.27	-92.57
Attributable To Parent	63.59%-230.38	-632.78	-61.94	-67.25	-92.56
Available To Common Stockholders, Basic	63.59%-230.38	-632.78	-61.94	-67.25	-92.56
Attributable To Noncontrolling Interest	20.00%-0.01	-0.02	-0.01	-0.02	-0.02
Basic Average Shares	2.26%1,050.07	1,026.87	23.53	946.60	888.22
Diluted Average Shares	2.26%1,050.07	1,026.87	23.53	946.60	888.22
Basic Earnings Per Share	64.52%-0.22	-0.62	-0.06	-0.07	-0.10
Diluted Earnings Per Share	64.52%-0.22	-0.62	-0.06	-0.07	-0.10